299660.KQ
Cellid, Co., Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 2,405.00
−1.03%Year over year
Reported trailing growth
- Revenue
- +49.9%
- EBITDA
- -51.3%
- EBIT
- +4.7%
- EPS
- -41.7%
- Free cash flow
- +26.9%
- Operating cash flow
- -40.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +164.1%
- EBITDA
- -1.5%
- EBIT
- +2.3%
- Net income
- +1.5%
- EPS
- +41.1%
- Free cash flow
- +19.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026